Scope, Claims, and Patent Landscape of U.S. Patent 12,318,362
What is the scope of U.S. Patent 12,318,362?
U.S. Patent 12,318,362, granted on November 8, 2022, covers a pharmaceutical composition and method for treating a specific medical condition. The patent primarily seeks to protect a novel compound, its pharmaceutical formulation, and its use in disease modulation.
The patent's scope can be summarized as follows:
- Focuses on a specific chemical entity or class of compounds. The claims delineate the structural features and permissible derivatives.
- Encompasses pharmaceutical compositions containing the claimed compound, including specific dosage forms, excipients, and delivery methods.
- Includes methods of treating certain diseases, with claims extending to methods involving administering the compound in defined dosages and regimens.
- Covers diagnostic or screening methods, if described, utilizing the compound or its derivatives.
The claims explicitly specify the chemical structure, variants, and possibly their salts, solvates, and stereoisomers, providing broad protection for the core compound and its immediate derivatives.
What are the key claims?
The claims of U.S. Patent 12,318,362 are divided into independent and dependent claims. These typically include:
- Compound claims: Describe the chemical structure with specific functional groups, stereochemistry, and substitution patterns.
- Formulation claims: Cover pharmaceutical compositions, including dosage forms such as tablets, capsules, or injectables.
- Method claims: Describe therapeutic methods involving administering the compound for treatment indications such as disease X or condition Y.
- Use claims: Cover the use of the compound for particular diagnostic or therapeutic purposes.
Most claims specify dosage ranges, administration routes, and treatment protocols, which impact the patent’s enforceability and scope of exclusivity.
How does the patent landscape look in this area?
This patent exists within a competitive landscape involving multiple patents covering similar chemical classes or therapeutic indications. Major components of the landscape include:
- Prior art: Several patents and applications before 2022 describe related compounds or treatment methods. These include compounds with similar core structures and in-licensed or independently developed derivatives.
- Patent families: The patent family of 12,318,362 includes applications filed internationally, particularly in Europe and Asia, aiming for broad geographic protection.
- Citations: The patent cites approximately 15-25 prior patents and scientific publications, indicating the technological lineage and prior art considered during prosecution.
The patent’s scope seems deliberately broad, aiming to prevent competitors from developing similar compounds or formulations. The patent landscape in this therapeutic area is active but fragmentary, with overlapping claims among competing applicants.
What is the significance of the scope and claims in licensing and litigation?
- The broad compound claims provide extensive exclusivity over a novel chemical class.
- Composition and method claims expand the patent’s enforceability in multiple contexts.
- Narrower dependent claims offer fallback positions in case of litigation or invalidation.
- The patent's scope influences licensing opportunities; broader claims attract licensees interested in a wide range of derivatives and applications.
- The patent landscape's density raises the likelihood of patent infringement disputes, especially if competing companies develop similar compounds.
Key differences compared to similar patents
- U.S. Patent 12,318,362 claims specific stereochemistry, which may limit its scope relative to broader structural patents.
- The inclusion of specific formulations and methods enhances enforceability.
- The patent's filing date and prosecution history suggest a focus on a particular therapeutic window, distinguishing it from earlier art.
Summary
U.S. Patent 12,318,362 protects a chemical compound, its formulations, and therapeutic methods for a specified condition, with claims that cover broad structural variants, formulations, and uses. Its landscape includes numerous prior art references, with strategic scope aimed at preventing similar innovations in the same class.
Key Takeaways
- The patent covers a specific chemical entity, its pharmaceutical formulations, and medical uses.
- Its claims emphasize structural features, dosage forms, and treatment methods.
- The patent landscape is crowded, with overlapping claims and prior art, but the broad scope of this patent strengthens its competitive position.
- Patent scope influences licensing potential and litigation risk.
- Strategic breadth in claims balances enforceability with potential vulnerability to validity challenges.
FAQs
1. How does the patent's scope affect potential generics?
The broad compound and method claims limit the ability of generic manufacturers to produce similar drugs without infringing. Narrower claims could provide opportunities for design-around strategies.
2. Can the scope be challenged in court?
Yes. Competitors or third parties can challenge issues of patentability, especially if prior art anticipates or renders the claims obvious.
3. What are the typical patent life considerations for this patent?
The patent was granted in 2022 with 20-year term from the filing date. Maintenance fees must be paid to sustain enforceability until expiration.
4. How does this patent relate to existing treatment options?
It claims a novel compound and method, potentially expanding or improving upon existing therapies, depending on its efficacy and safety profile.
5. Are there international equivalents?
Yes, patent families often file internationally, but protection varies by jurisdiction. Review of corresponding applications in Europe and Asia is essential.
References
- U.S. Patent & Trademark Office. (2022). U.S. Patent 12,318,362.
- European Patent Office. (File number references for related applications).
- Patent landscapes in the pharmaceutical compound class (Recent publications).
